Slocum, Gordon & Co’s Organon & Co OGN Stock Holding History

Slocum, Gordon & Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20	Closed	-$558	–	147
2022 Q4	$558	Buy	+20	New	+$511	﹤0.01%	134

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Slocum, Gordon & Co's OGN Position: Q1 2023 in Review

Slocum, Gordon & Co sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 20 shares — an estimated $558 sold.

Slocum, Gordon & Co first reported a position in OGN in Q4 2022 and held it in 1 quarter. The position peaked at $558 in Q4 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

Slocum, Gordon & Co reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
Slocum, Gordon & Co sold 20 Organon & Co shares in Q1 2023, an estimated $558.
Slocum, Gordon & Co first reported a position in Organon & Co in Q4 2022 and held it in 1 quarter.
Slocum, Gordon & Co's Organon & Co position peaked at $558 in Q4 2022.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Slocum, Gordon & Co's 13F filing for Q1 2023, filed 14 Dec 2023.